REVIEWThe placebo–nocebo response: Controversies and challenges from clinical and research perspective
Introduction
“Fortis imaginatio generat casum”
A powerful imagination generates the event
(Michel de Montaigne)
The placebo–nocebo phenomenon is subject to an increasing and heated debate, and extensive controversial research. For time being it represents a huge challenge to contemporary psychiatry as well as to medicine in general. Although “the history of medicine is the history of placebo” (Czerniak and Davidson, 2012), it is not only a conundrum (Jubb and Bensing, 2013), but a big puzzle wrapped into the great mystery of human body, brain and mind relationships. In modern clinical psychopharmacology neutral substance wrongly called placebo has been mainly used as a comparison factor rather than being studied while phenomenon of nocebo has been studied even less extensively than placebo. Placebo–nocebo challenge includes quite a number of conceptual, explanatory and moral questions and dilemmas. Conceptual questions are related to the cacophony regarding various definitions and meanings of terms like fake, slam or dummy treatment; pharmaceuticals and neutraceuticals; placebo treatment; multiple placebo effects; inert and active placebo, true and perceived placebo; pure and impure placebo, placebogenic and nocebogenic effects; placebo and nocebo effect or response; placebo and nocebo induction; negative placebo effect, placebo adverse reaction, placebo induced side-effect, negative placebo response, reverse placebo effect, antiplacebo; iatrogenic effects due to diagnosis and treatment, context effects and meaning responses. Questions concerning the function of neutral control treatment in research are very important from both ethical and methodological perspective. Explanatory or epistemological questions are relevant to mechanisms underlying placebo–nocebo phenomenon related to mind-body operating systems and psychosomatic networks, treatment context, doctor–patient relationship, suggestion and auto-suggestion, deception and self-deception and self-fulfilling prophecies, interactions between specific and nonspecific mechanisms of change and therapeutic action. Placebo–nocebo phenomenon is multifactorial, multidimensional and etiologically complex and that is why explanatory models should refer mostly to explanatory pluralism rather than to reductionism. Moral or ethical questions are about the supposed use of neutral or fake treatment should be used. These questions, although very important, are beyond the scope of this article.
The use of imprecise thinking and language in mind-body medicine associated with conceptual cacophony, mythology and misconceptions (see Table 1) has been leading to a confusion in placebo–nocebo research and understanding as well as to a widespread disconnect between clinical practice guidelines, patients’ attitudes, and physicians’ practice (Hull et al., 2013). As there is no consensus regarding terminology, this review focuses first on conceptual chaos and different connotations in placebo–nocebo medicine, then on some new perspectives on placebo–nocebo phenomenon in the frame of creative psychopharmacotherapy and transdisciplinary integrative psychiatry.
Section snippets
Contradicting definitions: What's in the name?
The words placebo and nocebo are used with many different meanings associated with a lot of controversies. Regarding the neutral, inert, pharmacologically/biologically inactive, fake or deceptive treatment, given as if it was a real treatment, the very fundamental question is what is more appropriate to talk about “the effect of” or “response to” the such kind of treatment. Today an interchangeable use of the terms ‘placebo effect’ and ‘placebo response’ as synonyms is a trend (Benedeti, 2013).
Two sides of the same coin or different currency?
“If patients can't imagine a good result, they won't experience a good result” (Vertosick, 2000).
Any medical or psychosocial treatment has two components, one related to the specific effects of a treatment itself (so called “characteristic constituents of a treatment”) and the other related to the individual perception, imagination and subjective meaning and experience. The latter is labeled as incidental constituents of a treatment (see McQueen et al., 2013) including placebogenic and
How words, beliefs and rituals change the human brain: The role of suggestion, deception and self-deception
Faith has always played a strong role as a popular measure of cure
Sir William Osler
History of psychiatry, as well as of medicine in general, in some way is a history of placebo or nocebo rituals or remedies and “a humiliating memorial of the credulity and infatuations of the physicians” who recommended and prescribed remedies which were not known to be inert or event dangerous (Jopling, 2008). Our “belief system”, an important part of our mental model, which “programs” us how to deal with any
The evidence-based medicine, clinical trials and placebo–nocebo phenomenon
Evidence based medicine has become the gospel of truth in modern psychiatry, the double-blind randomized clinical trial despite its limitations has obtained a status of the golden standard in clinical psychopharmacology, while inactive or neutral comparator wrongly called placebo “has turned into an indispensable instrument” (Stein, 2008, Touwen and Engberts, 2012). Placebo and nocebo responses occur in both active and non-active treatment groups, since they are related to the treatment context
The placebo–nocebo phenomenon in everyday clinical practice
“He cures most successfully in whom the people have the most confidence” (Galen)
Psychopharmacotherapy is a context dependent practice because different treatment contexts may affect the meaning of biological variables in different ways. Patients are not just neurobiological objects who respond only neurochemically to medications, but also subjects who respond to the meaning that prescribed medications have for them and their psychiatrists (Mintz, 2005). Treatment outcome depends on a complex
The placebo–nocebo response to informed consent
“Medications are guilty until proven innocent”
(Oliver Wendel Holmes 1861)
In contrast to paternalism, one of the fundamental principles of professionalism in psychiatry and health care (see Jakovljevic, 2012a) is to obtain informed consent from patients before any treatment. In addition, informed consent is a precondition for patients’ inclusion in randomized controlled clinical trials. However, the informed consent has also two sides, positive one and negative one. The bad news here is that
Creative psychopharmacotherapy, good clinical practice and placebo–nocebo response
“The practice of medicine is an art based on science”
Sir William Osler
Modern psychiatry and medicine in general tend to disregard the idea of deliberately maximizing the placebo response linking it with pre-scientific medicine and with unethical and deceitful practices (Verhulst et al., 2013). There is a lack of conceptual frameworks that integrate placebo healing into standard clinical practice as well as medical education programs that specifically teach this (Verhulst et al., 2013). It has
Conclusions
Any medical or psychosocial treatment has two components, one associated with the specific effects of the treatment itself and the other related to the treatment context, individual perception, imagination, subjective meaning and psychobiological response. Understanding the placebo and nocebo phenomenon and its psychobiological underpinnings, as well as mastering placebo–nocebo responses in everyday clinical practice and the use of comparative treatments in clinical trials represent a great
Role of funding source
There is no funding source regarding the article.
Contributors
There are no contributors to the article.
Conflict of interest
There is no conflict of interest regarding the article.
Acknowledgement
There are no acknowledgements regarding the article.
References (60)
- et al.
The placebo response: how words and rituals change the patient's brain
Patient Edu. Counsel.
(2011) Placebo-induced improvement: how therapeutic rituals affect the patient's brain
J. Acupunct. Meridian Stud.
(2012)- et al.
Placebo, a historical perspective
Eur. Neuropsychopharmacol.
(2012) - et al.
The placebo arm in clinical studies for treatment of psychiatric disorders: a regulatory dilemma
Eur. Neuropsychopharmacol.
(2012) How faith heals: a theoretical model
Explore
(2009)The spectrum of behaviors influenced by serotonin
Biol. Psychol.
(1998)- et al.
Why medication in involuntary treatment may be less effective: the placebo/nocebo effect
Med. Hypotheses
(2011) - et al.
Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions
Pharmacol. Ther.
(2013) Optimism, pessimism, and mortality
Mayo Clin. Proc.
(2000)- et al.
Those famous red pills—deliberations and hesitations. Ethics of placebo use in therapeutic and research settings
Eur. Neuropsychopharmacol.
(2012)
Head to head comparisons as an alternative to placebo-controlled trials
Eur. Neuropsychopharmacol.
Psychobiological model of personality and psychopharmacotherapy outcomes in treatment of depression and schizophrenia
Psychiatria Danubina
Placebo, meaning and health
J. Perspect. Biol. Med.
Mechanisms of placebo and placebo-related effects across diseases and treatments
Ann. Rev. Pharmacol. Toxicol.
The Patient's Brain: The Neuroscience Behind the Doctor–Patient Relationship
How placebos change the patient's brain
Neuropsychopharmacology
Placebo and the new physiology of the doctor–patient relationship
Physiol. Rev.
Understanding placebo, nocebo, and iatrogenic treatment effects
J. Clin. Psychol.
The nocebo effect of informed consent
Bioethics
The nocebo effect and its relevance for clinical practice
Psychosom. Med.
How placebo responses are formed: a learning perspective
Philos. Trans. R. Soc. B
The placebo response in medicine: minimize, maximize or personalize?
Nat. Rev./Drug Discovery
Personalized pharmacotherapy in psychiatry
Psychiatria Danubina
The nocebo phenomenon: scope and foundations
Nocebo phenomena in medicine: their relevance in every day clinical practice
Dtsch. Arztebl. Int.
Patients’ attitude about the use of placebo treatments: telephone survey
BMJ
An explanation for the placebo effect?
Science
How to increase treatment effectiveness and efficiency in psychiatry. Creative psychopharmacotherapy. Part 1. Definition, fundamental principles and higher effectiveness polipharmacy.
Psychiatria Danubina
How to increase treatment effectiveness and efficiency in psychiatry. Creative psychopharmacotherapy. Part 2. Creating favorable treatment context and fostering patients’ creativity
Psychiatria Danubina
Cited by (43)
How to determine whether conceptual endophenotypes can improve clinical outcomes in patients suffering from major depression: An exploratory approach
2019, PsychoneuroendocrinologyCitation Excerpt :The patients knew whether they had been included in the treatment as usual (SG) or IG/Neuropattern group with the expected better response, expected by both the patients and the clinicians. Therefore, we cannot exclude a Hawthorne, Rosenthal or other effects related to non-blinding as possible explanation for the between-group effects (Jakovljevic, 2014; McCambridge et al., 2014). Such effects nevertheless cannot account for potentially specific findings of a particular Neuropattern presented in our analysis.
Thermal and non-thermal health effects of low intensity non-ionizing radiation: An international perspective
2018, Environmental PollutionThe nocebo effect: Various aspects and consequences in clinical practice
2018, Revue de Medecine InterneDiagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)
2016, Canadian Journal of CardiologyCitation Excerpt :These are often further fertilized with colourful stickers on the prescription bottles advising against the use of grapefruit juice and potentially magnified by the internet's often unsubstantiated repository of information that is devoid of clinical perspective or judgement. Much needless worry can be avoided by careful attention to this aspect of the physician-patient interaction.39-52 Although this counselling, even when given by professional dieticians and exercise physiologists, might not always have the intended effects, it is nevertheless a cornerstone of chronic dyslipidemia and CV risk management that can help achieve lipid goals, perhaps minimize drug use, and ensure comprehensive CV risk reduction.